 Silvania Da Silva Teixeira
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Triiodothyronine | 8 | 2017 | 49 | 1.620 |
Why?
| | Phosphatidylinositol 3-Kinases | 4 | 2020 | 354 | 1.070 |
Why?
| | Calcitriol | 1 | 2020 | 50 | 0.870 |
Why?
| | Vitamins | 1 | 2020 | 123 | 0.820 |
Why?
| | Insulin | 7 | 2020 | 1972 | 0.760 |
Why?
| | Diiodothyronines | 1 | 2016 | 4 | 0.720 |
Why?
| | Insulin Resistance | 4 | 2016 | 1076 | 0.620 |
Why?
| | Glucose Transporter Type 4 | 3 | 2014 | 41 | 0.580 |
Why?
| | Neurons | 2 | 2020 | 1514 | 0.480 |
Why?
| | Symporters | 2 | 2016 | 58 | 0.470 |
Why?
| | Thyroid Hormones | 2 | 2011 | 49 | 0.440 |
Why?
| | Blood Glucose | 2 | 2016 | 1689 | 0.390 |
Why?
| | Receptors, Thyroid Hormone | 2 | 2008 | 24 | 0.380 |
Why?
| | Sodium Iodide | 1 | 2016 | 3 | 0.340 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2017 | 214 | 0.310 |
Why?
| | Valerates | 1 | 2014 | 1 | 0.310 |
Why?
| | Glycogen Synthase Kinase 3 | 2 | 2017 | 89 | 0.300 |
Why?
| | RNA, Messenger | 3 | 2012 | 2914 | 0.270 |
Why?
| | Muscle, Skeletal | 3 | 2016 | 1333 | 0.270 |
Why?
| | Glucose Transporter Type 3 | 1 | 2012 | 11 | 0.260 |
Why?
| | Proinsulin | 1 | 2012 | 48 | 0.260 |
Why?
| | Glucose Transporter Type 1 | 1 | 2012 | 50 | 0.250 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2012 | 155 | 0.230 |
Why?
| | Signal Transduction | 4 | 2020 | 4845 | 0.230 |
Why?
| | Dietary Supplements | 1 | 2014 | 404 | 0.230 |
Why?
| | Glucose | 2 | 2012 | 819 | 0.220 |
Why?
| | Rats, Long-Evans | 1 | 2020 | 130 | 0.220 |
Why?
| | Rats | 8 | 2017 | 6717 | 0.220 |
Why?
| | Trans-Activators | 1 | 2012 | 406 | 0.210 |
Why?
| | Cell Line | 3 | 2020 | 2946 | 0.210 |
Why?
| | Hypothalamus | 1 | 2020 | 201 | 0.200 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 472 | 0.200 |
Why?
| | Transcription, Genetic | 1 | 2016 | 1472 | 0.200 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2566 | 0.200 |
Why?
| | RANK Ligand | 1 | 2008 | 25 | 0.190 |
Why?
| | Animals | 11 | 2020 | 34264 | 0.180 |
Why?
| | Bone Resorption | 1 | 2008 | 73 | 0.180 |
Why?
| | Osteoblasts | 1 | 2008 | 93 | 0.180 |
Why?
| | Osteosarcoma | 1 | 2008 | 76 | 0.180 |
Why?
| | Neurodegenerative Diseases | 1 | 2017 | 68 | 0.180 |
Why?
| | Hep G2 Cells | 1 | 2016 | 65 | 0.180 |
Why?
| | Adipose Tissue | 2 | 2016 | 625 | 0.170 |
Why?
| | Enzyme Activation | 3 | 2017 | 975 | 0.160 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 378 | 0.160 |
Why?
| | Estrogens | 1 | 2008 | 310 | 0.150 |
Why?
| | Diet, High-Fat | 1 | 2016 | 225 | 0.150 |
Why?
| | Congenital Hypothyroidism | 1 | 2004 | 12 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2016 | 458 | 0.150 |
Why?
| | Obesity | 2 | 2020 | 2565 | 0.150 |
Why?
| | Rats, Wistar | 3 | 2017 | 444 | 0.150 |
Why?
| | Iodides | 1 | 2014 | 9 | 0.150 |
Why?
| | Mice, Transgenic | 1 | 2020 | 2151 | 0.140 |
Why?
| | Hypothyroidism | 1 | 2004 | 74 | 0.140 |
Why?
| | Phosphorylation | 4 | 2014 | 1765 | 0.140 |
Why?
| | Thyroid Gland | 1 | 2014 | 94 | 0.140 |
Why?
| | Peptide Initiation Factors | 1 | 2012 | 16 | 0.130 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2012 | 14 | 0.130 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2012 | 45 | 0.130 |
Why?
| | Hippocampus | 1 | 2017 | 862 | 0.120 |
Why?
| | Energy Metabolism | 1 | 2016 | 905 | 0.110 |
Why?
| | Biotinylation | 2 | 2014 | 33 | 0.100 |
Why?
| | RNA-Binding Proteins | 1 | 2012 | 335 | 0.100 |
Why?
| | Reactive Oxygen Species | 2 | 2016 | 521 | 0.100 |
Why?
| | Insulin-Secreting Cells | 1 | 2012 | 296 | 0.100 |
Why?
| | Cell Membrane | 2 | 2012 | 760 | 0.090 |
Why?
| | Cytokines | 1 | 2016 | 1868 | 0.090 |
Why?
| | Male | 5 | 2020 | 58392 | 0.090 |
Why?
| | PAX8 Transcription Factor | 1 | 2016 | 2 | 0.090 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2016 | 5 | 0.090 |
Why?
| | Cell Line, Tumor | 3 | 2012 | 2770 | 0.080 |
Why?
| | Mice, Inbred C57BL | 1 | 2016 | 4997 | 0.080 |
Why?
| | Thyrotropin | 1 | 2016 | 104 | 0.080 |
Why?
| | Cycloheximide | 1 | 2012 | 64 | 0.070 |
Why?
| | Dactinomycin | 1 | 2012 | 29 | 0.070 |
Why?
| | Glucose Tolerance Test | 1 | 2014 | 369 | 0.070 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2012 | 20 | 0.070 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2012 | 63 | 0.070 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 384 | 0.070 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2012 | 49 | 0.070 |
Why?
| | Down-Regulation | 1 | 2016 | 684 | 0.070 |
Why?
| | Cell Nucleus | 1 | 2016 | 601 | 0.060 |
Why?
| | Neoplasm Proteins | 1 | 2016 | 431 | 0.060 |
Why?
| | Deoxyglucose | 1 | 2012 | 59 | 0.060 |
Why?
| | Thyroidectomy | 1 | 2011 | 57 | 0.060 |
Why?
| | Blotting, Northern | 1 | 2011 | 235 | 0.060 |
Why?
| | Polyadenylation | 1 | 2011 | 32 | 0.060 |
Why?
| | Blotting, Western | 1 | 2014 | 1375 | 0.060 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1260 | 0.060 |
Why?
| | Mice | 1 | 2016 | 14765 | 0.050 |
Why?
| | Protein Transport | 1 | 2011 | 448 | 0.050 |
Why?
| | Electrophoresis, Agar Gel | 1 | 2008 | 31 | 0.050 |
Why?
| | Osteoclasts | 1 | 2008 | 24 | 0.050 |
Why?
| | Thyroxine | 1 | 2017 | 65 | 0.050 |
Why?
| | Alloxan | 1 | 2016 | 4 | 0.040 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2017 | 166 | 0.040 |
Why?
| | Gene Expression | 1 | 2011 | 1525 | 0.040 |
Why?
| | Liver | 1 | 2014 | 1802 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 1154 | 0.040 |
Why?
| | Inflammasomes | 1 | 2016 | 114 | 0.040 |
Why?
| | Humans | 4 | 2016 | 104249 | 0.040 |
Why?
| | Anions | 1 | 2014 | 42 | 0.040 |
Why?
| | Cell Survival | 1 | 2017 | 1106 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2012 | 4339 | 0.030 |
Why?
| | Superoxides | 1 | 2014 | 242 | 0.030 |
Why?
| | Insulinoma | 1 | 2012 | 28 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2016 | 514 | 0.030 |
Why?
| | Protein Biosynthesis | 1 | 2012 | 390 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2008 | 1729 | 0.030 |
Why?
| | Models, Animal | 1 | 2012 | 392 | 0.030 |
Why?
| | Phosphoproteins | 1 | 2012 | 344 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2014 | 944 | 0.030 |
Why?
| | Oxygen | 1 | 2014 | 844 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 432 | 0.030 |
Why?
| | Mitochondria | 1 | 2014 | 720 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2012 | 810 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2242 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 2012 | 672 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2016 | 8608 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2012 | 3738 | 0.020 |
Why?
| | Middle Aged | 1 | 2008 | 27633 | 0.010 |
Why?
| | Female | 1 | 2008 | 59707 | 0.010 |
Why?
|
|
Da Silva Teixeira's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|